UroGen Pharma Ltd. (NASDAQ:URGN) Q2 2023 Earnings Call Transcript

UroGen Pharma Ltd. (NASDAQ:URGN) Q2 2023 Earnings Call Transcript August 10, 2023

UroGen Pharma Ltd. beats earnings expectations. Reported EPS is $-1.03, expectations were $-1.13.

Operator: Good morning, ladies and gentlemen. Thank you for standing by. And welcome to the UroGen Pharma’s Second Quarter 2023 Earnings Call. Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker today, Vincent Perrone, Head Investor Relations....